Hims & Hers: Driving Growth In Wellness

Yiannis Zourmpanos profile picture
Yiannis Zourmpanos
7.74K Followers
(11min)

Summary

  • Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users.
  • Q3 2024 revenue rose 77% YoY to $401.6M, with $392.6M from online channels (+79% YoY).
  • GLP-1 patient retention at 12 weeks reached 70%, outperforming the industry average of less than 42%.
  • Customers reported 4.1% body weight loss in 4 weeks, improving to 5.5% by 8 weeks.
  • Adding liraglutide in 2025 and scaling 503A facilities to boost personalized care and subscriber growth.

Artificial Intelligence in Healthcare, AI Health, digital healthcare provider, telemedicine, medical technology

Just_Super/E+ via Getty Images

Investment Thesis

Hims & Hers Health, Inc. (NYSE:HIMS) leads the fast-growing health and wellness market using its technology-based platform to offer personalized, accessible care. The company has been a pioneer in subscription-based healthcare, driving substantial revenue and subscriber

This article was written by

Yiannis Zourmpanos profile picture
7.74K Followers
Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. Investment Style: We focus on GARP/Value stocks—high-quality, reasonably priced businesses with strong moats and significant growth potential. We prioritize fundamentals and seek stocks trading at a discount to intrinsic value, with a clear margin of safety. Our long-term approach (5-7 years) aims for wealth accumulation through compounding while emphasizing downside protection and sometimes taking contrarian views during market uncertainties.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About HIMS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on HIMS

Related Stocks

SymbolLast Price% Chg
HIMS
--